Drug formulation: Injection of sterile drug solution: Biotype: Anticoagulant: 50 ml of a drug containing one mg of enrofloxacin. The mechanism of action of the drug: May is an enrofloxacin which is a third generation of fluoroquinolones, which, based on its function, inhibits the DNA-Gyrase DNA enzyme in the nucleus of the bacterial cell and converts it into small and inactive parts and prevents the DNA from replicating its bactericidal effects Apply. % 5 spectrum of enrofloxacin has a great effect and against the negative Roma bacteria such as Escherichia coli, Klebsiella, Salmonella, Proteus, Campylobacter, Bradutla, Pasteurela, Hemophilus, Actinobacillus, Brucella, Pseudomonas aeruginosa and Gram-positive bacteria such as Staphylococcus, Streptococcus, Coriander bacterium , Clostridium, Listeria monocytogenes, Arcanobacterium piogenesis, Erizoplotticus rosyopathy, Mycoplasma and Chlamydia. The minimum number of acne The effective concentration of this drug is low against this, as a result of this specific pharmacokinetics and drug-related pharmacokinetic properties, the effective concentration of the drug concentration is rapidly evolving.